Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone
Science Advances · 09.08.2024 · 10 (32)
DOI: 10.1126/sciadv.adn1607 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 09.08.2024. Verfasst von Emily S Norton und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Mayo Clinic, Jacksonville, FL 32224, USA. Hauptthemen laut MEDLINE: Glioblastoma, Cathepsin B, Proteomics, Lateral Ventricles. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most prevalent and aggressive malignant primary brain tumor. GBM proximal to the lateral ventricles (LVs) is more aggressive, potentially because of subventricular zone contact. Despite this, cross-talk between GBM and neural stem/progenitor cells (NSC/NPCs) is not well understood. Using cell-specific proteomics, we show that LV-proximal GBM prevents neuronal maturation of NSCs through induction of senescence. In addition, GBM brain tumor–initiating cells (BTICs) increase expression of cathepsin B (CTSB) upon interaction with NPCs. Lentiviral knockdown and recombinant protein experiments reveal that both cell-intrinsic and soluble CTSB promote malignancy-associated phenotypes in BTICs. Soluble CTSB stalls neuronal maturation in NPCs while promoting senescence, providing a link between LV-tumor proximity and neurogenesis disruption. Last, we show LV-proximal CTSB up-regulation in patients, showing the relevance of this cross-talk in human GBM biology. These results demonstrate the value of proteomic analysis in tumor microenvironment research and provide direction for new therapeutic strategies in GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Mayo Clinic, Jacksonville, FL 32224, USA.
- Neuroscience Graduate Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL 32224, USA.
- Regenerative Sciences Training Program, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Jacksonville, FL 32224, USA.
- Department of Biology, University of North Florida, Jacksonville, FL 32224, USA.
- Department of Neuroscience, Mayo Clinic, Jacksonville, FL 32224, USA.
- Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Jacksonville, FL 32224, USA.
ORCID-Profile: Emily S Norton, Lauren A Whaley, Vanessa K Jones, Dmytro Morderer, Natanael Zarco, Anna Carrano, Wilfried Rossoll, Yan W Asmann, TuKiet T Lam, Panos Z Anastasiadis, Hugo Guerrero-Cázares
Förderung
- NINDS NIH HHS
- NIH HHS
Zitieren
APA
Norton, E. S., Whaley, L. A., Jones, V. K., Brooks, M. M., Russo, M. N., Morderer, D., Jessen, E., Schiapparelli, P., Ramos-Fresnedo, A., Zarco, N., Carrano, A., Rossoll, W., Asmann, Y. W., Lam, T. T., Chaichana, K. L., Anastasiadis, P. Z., Quiñones-Hinojosa, A., & Guerrero-Cázares, H. (2024). Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone. Science Advances, 10(32). https://doi.org/10.1126/sciadv.adn1607
Vancouver
Norton ES, Whaley LA, Jones VK, Brooks MM, Russo MN, Morderer D, et al. Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone. Science Advances. 2024;10(32). doi:10.1126/sciadv.adn1607
BibTeX
@article{Norton2024,
author = {Norton, Emily S and Whaley, Lauren A and Jones, Vanessa K and Brooks, Mieu M and Russo, Marissa N and Morderer, Dmytro and Jessen, Erik and Schiapparelli, Paula and Ramos-Fresnedo, Andres and Zarco, Natanael and Carrano, Anna and Rossoll, Wilfried and Asmann, Yan W and Lam, TuKiet T and Chaichana, Kaisorn L and Anastasiadis, Panos Z and Quiñones-Hinojosa, Alfredo and Guerrero-Cázares, Hugo},
title = {Cell-specific cross-talk proteomics reveals cathepsin B signaling as a driver of glioblastoma malignancy near the subventricular zone},
journal = {Science Advances},
year = {2024},
volume = {10},
number = {32},
doi = {10.1126/sciadv.adn1607}
}
EUVIMED